1. Survival Improvements in Adolescents and Young Adults after Myeloablative Allogeneic Transplantation for Acute Lymphoblastic Leukemia 
William A. Wood, Stephanie J. Lee, Ruta Brazauskas, Zhiwei Wang, Mahmoud D. Aljurf, Karen K. Ballen, David K. Buchbinder, Jason Dehn, Cesar O. Freytes, Hillard M. Lazarus, Charles F. LeMaistre, Paulette Mehta, David Szwajcer, Steven Joffe, Navneet S. Majhail 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 6, Pages (June 2014)
DOI: /j.bbmt
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Five-year adjusted overall survival probabilities for each age group over time (the lines in the box represent survival probability and the ends of the box represent 95% confidence intervals).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Outcomes for AYAs 15 to 25 years of age who underwent transplantation between 2002 and (A) Shows overall survival. (B) Shows leukemia-free survival. (C) Shows treatment-related mortality. (D) Shows relapse.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions